Business
MGC Pharma makes strong debut as London Stock Exchange’s first medicinal cannabis company – Stockhead
MGC Pharma is the first medicinal cannabis company to be admitted to the London Stock Exchange Admission follows successful IPO for $11.6m from sophisticated and…
Link copied toclipboard
- MGC Pharma is the first medicinal cannabis company to be admitted to the London Stock Exchange
- Admission follows successful IPO for $11.6m from sophisticated and institutional investors
- Shares in MGC Pharma rise 60 per cent on LSE trading debut as listing was well received by investors
The share price of medicinal cannabis company MGC Pharmaceuticals (ASX:MXC) soared 60 per cent Tuesday on its first day of trading on the London Stock Exchange (LSE).
MGC Pharma is the first medicinal…
Continue Reading
-
General9 hours agoRSL NSW president Mick Bainbridge and three board members resign in wake of 7.30 investigation into conflicts of interest
-
General12 hours agoSelf-taught child drummer makes rock band debut with The Living End
-
Noosa News16 hours agoWave of cruises headed for Sunshine Coast this summer
-
General20 hours agoNewsCorp executive warns AI firms are asking Australia to ‘surrender our stories’